Clinical Trials Directory

Trials / Completed

CompletedNCT02151240

Efficacy and Safety of Foscarnet Sodium and Sodium Chloride Injection in Patients With Herpes Zoster

A Multi-centered, Randomized Study to Evaluate the Efficacy and Safety of Foscarnet Sodium and Sodium Chloride Injection Compared to Intravenous Acyclovir in Patients With Herpes Zoster From China

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
94 (actual)
Sponsor
Cttq · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of Foscarnet Sodium and Sodium Chloride Injection in patients with herpes zoster, and observe incidence of Postherpetic neuralgia

Conditions

Interventions

TypeNameDescription
DRUGFoscarnet Sodium
DRUGAcyclovir

Timeline

Start date
2014-05-01
Primary completion
2015-05-01
Completion
2019-07-01
First posted
2014-05-30
Last updated
2021-06-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02151240. Inclusion in this directory is not an endorsement.